Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Emma Reeve | F | 63 | 3 years | |
| Bernadette Connaughton | F | 65 | 3 years | |
| Meeta Chatterjee | M | 69 | 4 years | |
| Chi Li | M | - | 3 years | |
| Piyush Sharma | M | - | 7 years | |
| Sarah Marshall | F | - | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Leonard Bell | M | 65 | 25 years | |
| Joseph A. Madri | M | 80 | 22 years | |
| David Brennan | M | 70 | 7 years | |
| David Hallal | M | 57 | 10 years | |
| David Guyer | M | 64 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 5 years |
| Stephen P. Squinto | M | 67 | 23 years | |
| Cynthia Collins | F | 65 | 3 years | |
| Jack Mollen | M | 73 | 7 years | |
| William Keller | M | 75 | 6 years | |
| Brian Goff | M | 55 | 4 years | |
| Rana Strellis | F | - | 4 years | |
| Marty Glick | M | 74 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | - |
| Max E. Link | M | 84 | 22 years | |
| M. Burns | F | 66 | 4 years | |
| Mark Day | M | 52 | 2 years | |
| Felix Baker | M | 55 | 6 years | |
| Tina Beamon | F | - | 3 years | |
| Larry L. Mathis | M | 80 | 10 years | |
| Christopher Coughlin | M | 71 | 7 years | |
| Lisa M. DeFrancesco | F | 45 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | 5 years |
| Christopher Bodine | M | 68 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | 4 years |
| Scott Peters | M | - | 8 years | |
| Lisa Lejuwaan | F | - | - | |
| Charles M. Mayr | M | 67 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | 5 years |
| Ludwig Hantson | M | 61 | 4 years | |
| Mark Shearman | M | 62 | - | |
| Derek Adams | M | 50 | 11 years | |
| Al Boyle | M | - | 6 years | |
| Romesh R. Subramanian | M | 58 | 3 years | |
| Joseph Newell | M | 54 | 2 years | |
| Ted Harding | M | - | 1 years | |
| James Engelhart | M | 60 | 2 years | |
| Julie O'Neill | F | 58 | 3 years | |
| John Tilton | M | 56 | 10 years | |
| Mittie Doyle | M | 59 | 3 years | |
| Edward Miller | M | 59 | 3 years | |
| Cheryl Nash | F | - | 4 years | |
| Anthony Pascucci | M | - |
Rider University
| 4 years |
| Steve Weiss | M | 55 | 4 years | |
| Jason Meyenburg | M | 47 | 13 years | |
| Thomas-Christian Mix | M | 57 | 2 years | |
| Ross Smith | M | - |
Rider University
| 4 years |
| Martine Zimmermann | M | 55 | 7 years | |
| Rebecca Velez Frey | F | - | 5 years | |
| Behrad Derakhshan | M | 44 | 2 years | |
| George Llado | M | 58 | - | |
| Micah Zajic | M | 43 | 3 years | |
| Richard Riese | M | 61 | 3 years | |
| Daniel A. Bazarko | M | - | 9 years | |
| Matthew DeLawder | M | - | 5 years | |
| Brian Krex | M | 57 | 4 years | |
| Randy Teel | M | 45 | 2 years | |
| John V. W. Reynders | M | - | 6 years | |
| Massimiliano Colao | M | 59 | 3 years | |
| Melissa Manno | F | - | 2 years | |
| Nelson A. Zamora | M | - |
Rider University
| 4 years |
| Francis Reynolds | M | 61 |
Rider University
| 4 years |
| Jing Marantz | M | 59 | 2 years | |
| Andrew Forte | M | 65 |
Rider University
| 4 years |
| Loni da Silva | F | - |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 5 years |
| Linda Brooks | F | - |
Rider University
| 4 years |
| Mark Lindbloom | M | - |
Rider University
| 4 years |
| Glenn Sblendorio | M | 68 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 3 years |
| Thomas Dubin | M | 62 | 12 years | |
| Dominique Monnet | M | 65 | 1 years | |
| Patrice Coissac | M | 75 | 8 years | |
| Francis Wright | M | 76 | 2 years | |
| Vikas Sinha | M | 60 | 11 years | |
| James E. Bartolomei | M | 63 |
Rider University
| 4 years |
| Joel P. Brooks | M | 65 |
Rider University
| 4 years |
| David Harris | M | 64 |
Rider University
| 4 years |
| Christopher Carroll | M | 57 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 1 years |
| Karen Dykstra | F | 65 |
Rider University
| 4 years |
| John Cooper | M | 65 |
Rider University
| 4 years |
| Dave Anderson | M | 74 | 1 years | |
| Elena Ridloff | F | 44 | 4 years | |
| Gregory Senkevitch | M | - |
Rider University
| 4 years |
| Robert Manzo | M | 66 |
Rider University
| 4 years |
| David Lawrence Conover | M | 68 |
Rider University
| 4 years |
| Nicholas Ventura | M | - |
Rider University
| 4 years |
| Thomas Bock | M | 60 | 3 years | |
| Paul R. Tomkins | M | 66 |
Rider University
| 4 years |
| John K. Smith | M | - |
Rider University
| 4 years |
| Saqib Islam | M | 54 | 3 years | |
| Jeremy Springhorn | M | 61 | 9 years | |
| Martin MacKay | M | 68 | 4 years | |
| Bill Lundberg | M | 60 | 4 years | |
| James Bilotta | M | - | 10 years | |
| Paresh N. Soni | M | 63 | 2 years | |
| Claude Nicaise | M | 71 | 6 years | |
| Stephanie Fagan | F | - | 2 years | |
| Stephen E. Gerard | M | - |
Rider University
| 4 years |
| Barrett Katz | M | 74 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 years |
| Albert Paszek | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Clare M. Carmichael
- Personal Network
